Literature DB >> 25613061

Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.

D Frosini1, E Unti, F Guidoccio, C Del Gamba, G Puccini, D Volterrani, U Bonuccelli, R Ceravolo.   

Abstract

We investigated the striatal and extrastriatal DAT availability (SPM8) by [(123)I]FP-CIT-SPECT in 15 PD patients with depression and 35 PD patients without depression. A cluster with significant (p < 0.05) lower tracer binding in PD with depression was found in left cingulate cortex, persistent after correction for age, disease severity and duration, and inversely correlated with depression scores (r -0.336, p < 0.05). Our data indicate a significant association between PD depression and cingulate dopaminergic denervation supporting the dopaminergic hypothesis of PD depression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25613061     DOI: 10.1007/s00702-015-1370-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

Authors:  Marc J Mentis; Anthony R McIntosh; Kenneth Perrine; Vijay Dhawan; Brian Berlin; Andy Feigin; Christine Edwards; Paul Mattis; David Eidelberg
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Authors:  Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Olivier Rascol; Eduardo Tolosa; Daniel Weintraub
Journal:  Lancet Neurol       Date:  2010-05-07       Impact factor: 44.182

3.  Higher dopamine transporter density in Parkinson's disease patients with depression.

Authors:  Andre C Felicio; Tais S Moriyama; Clecio Godeiro-Junior; Ming C Shih; Marcelo Q Hoexter; Vanderci Borges; Sonia M A Silva; Edson Amaro-Junior; Luiz A F Andrade; Henrique B Ferraz; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2010-05-22       Impact factor: 4.530

4.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

Authors:  Daniel Weintraub; Andrew B Newberg; Mark S Cary; Andrew D Siderowf; Paul J Moberg; Galit Kleiner-Fisman; John E Duda; Matthew B Stern; David Mozley; Ira R Katz
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

5.  Depression in Parkinson's disease. Diffusion tensor imaging study.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Hidekazu Niikawa; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  J Neurol       Date:  2006-08-20       Impact factor: 4.849

6.  Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.

Authors:  David J Brunswick; Jay D Amsterdam; P David Mozley; Andrew Newberg
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

7.  Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody.

Authors:  S M Williams; P S Goldman-Rakic
Journal:  Cereb Cortex       Date:  1993 May-Jun       Impact factor: 5.357

8.  Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction.

Authors:  R Ceravolo; D Frosini; M Poletti; L Kiferle; C Pagni; S Mazzucchi; D Volterrani; U Bonuccelli
Journal:  Eur J Neurol       Date:  2012-10-18       Impact factor: 6.089

9.  Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.

Authors:  Chris Vriend; Pieter Raijmakers; Dick J Veltman; Karin D van Dijk; Ysbrand D van der Werf; Elisabeth M J Foncke; Jan H Smit; Henk W Berendse; Odile A van den Heuvel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-29       Impact factor: 10.154

10.  The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation.

Authors:  Piero Calvini; Guido Rodriguez; Fabrizio Inguglia; Alessandro Mignone; Ugo Paolo Guerra; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-08       Impact factor: 10.057

View more
  11 in total

Review 1.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

Review 2.  Chinese Herbal Medicine in the Treatment of Depression in Parkinson's Disease: From Molecules to Systems.

Authors:  Yi Zhang; Xiaoman Xu
Journal:  Front Pharmacol       Date:  2022-04-13       Impact factor: 5.988

3.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease.

Authors:  Stephanie L Alberico; Martin D Cassell; Nandakumar S Narayanan
Journal:  Basal Ganglia       Date:  2015-08-01

4.  Imaging analysis of Parkinson's disease patients using SPECT and tractography.

Authors:  Seong-Jin Son; Mansu Kim; Hyunjin Park
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

5.  Drug Choices and Advancements for Managing Depression in Parkinson's Disease.

Authors:  Francesca Assogna; Clelia Pellicano; Cinzia Savini; Lucia Macchiusi; Gaia R Pellicano; Marika Alborghetti; Carlo Caltagirone; Gianfranco Spalletta; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

6.  Alterations of Interhemispheric Functional Connectivity in Parkinson's Disease With Depression: A Resting-State Functional MRI Study.

Authors:  Haiyan Liao; Jie Fan; Qin Shen; Sainan Cai; Min Wang; Chunyu Wang; Hainan Zhang; Jun Liu; Xiongzhao Zhu; Changlian Tan
Journal:  Front Hum Neurosci       Date:  2020-06-05       Impact factor: 3.169

7.  Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI.

Authors:  Mahmood Nazari; Andreas Kluge; Ivayla Apostolova; Susanne Klutmann; Sharok Kimiaei; Michael Schroeder; Ralph Buchert
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

8.  CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice.

Authors:  Xiaojie Liu; Hao Yu; Bixuan Chen; Vladislav Friedman; Lianwei Mu; Thomas J Kelly; Gonzalo Ruiz-Pérez; Li Zhao; Xiaowen Bai; Cecilia J Hillard; Qing-Song Liu
Journal:  Biomedicines       Date:  2022-07-22

9.  Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.

Authors:  Enrico Premi; V D Calhoun; V Garibotto; R Turrone; A Alberici; E Cottini; A Pilotto; S Gazzina; M Magoni; B Paghera; B Borroni; A Padovani
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

10.  Aberrant Intra- and Internetwork Functional Connectivity in Depressed Parkinson's Disease.

Authors:  Luqing Wei; Xiao Hu; Yajing Zhu; Yonggui Yuan; Weiguo Liu; Hong Chen
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.